Transdermal Oestradiol Patches Non-inferior to LHRH Agonists Regarding Metastasis-Free Survival in Patients with Locally Advanced Prostate Cancer By Ogkologos - April 16, 2026 103 0 Facebook Twitter Google+ Pinterest WhatsApp Findings from a phase III study in patients recruited through the PATCH and STAMPEDE-1 trial networks Source RELATED ARTICLESMORE FROM AUTHOR Systemic Aging Associated with a Higher Risk of Early-Onset Solid Cancers Editor-in-Chief Opportunities for New ESMO Journals Launching in 2026 Blood Test May Help Identify Which Colorectal Cancer Patients with Liver Metastases Are Most Likely to Benefit from Chemotherapy After Surgery MOST POPULAR New on NCI’s Websites for September 2022 September 21, 2022 COVID-19 Vaccines Are Safe for People Receiving Cancer Immunotherapy, Study Confirms November 15, 2022 ΚΑΡΚΙΝΟΣ ΠΝΕΥΜΟΝΑ November 22, 2018 Evaluation of Primary and Secondary Prevention of Oral Cancer October 28, 2022 Load more HOT NEWS Adolescent and Young Adult Cancer Survivors Face More Co-morbidity in Later... FDA Granted Accelerated Approval to Belantamab Mafodotin-blmf for Multiple Myeloma FDA Approves Trastuzumab Deruxtecan for Any HER2-Positive Solid Cancer Trial Examines Value of Lymph Node Surgery in Advanced Ovarian Cancer
